| Financial Year |
March 31 2023 |
| Monetary Funds |
464,113,876.89 |
| Held-for-trading Financial Assets |
212,666,233.99 |
| Notes Receivable |
7,153,351.52 |
| Accounts Receivable |
74,478,209.59 |
| Advances to Suppliers |
3,664,182.11 |
| Other Receivables |
77,582.20 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
21,632,204.49 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
125,270.40 |
| Total Current Assets |
800,444,177.03 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
27,827,160.77 |
| Under-construction Projects |
48,465,928.27 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
19,871,312.27 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
2,105,198.15 |
| Deferred Income Tax Assets |
671,631.92 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
138,251,316.40 |
| Total Assets |
938,695,493.43 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
1,731,105.00 |
| Notes Payable |
19,822,869.28 |
| Accounts Payable |
35,819,129.94 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
4,784,896.73 |
| Taxes Payable |
5,807,664.29 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
562,450.00 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
311,699.28 |
| Other Current Liabilities |
64,058.50 |
| Sub-Total of Current Liabilities |
72,372,209.56 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,214,892.20 |
| Total Liabilities |
73,587,101.76 |
| Paid-In Capital(Or Share Stock) |
56,000,250.00 |
| Capital Surplus |
462,824,348.68 |
| Surplus Reserve |
30,840,689.88 |
| LESS:Treasury Stock |
3,336,444.50 |
| Undistributed Profits |
316,508,401.75 |
| Minority Stockholder's Interest |
2,271,145.86 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
862,837,245.81 |
| Owner's Equity（Stockholder's Equity） |
865,108,391.67 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
938,695,493.43 |
